On July 25, 2023, the Johns Hopkins University and the Johns Hopkins Health System Corporation (collectively “Johns Hopkins'') filed a notice of data breach with the Attorney General of.
/PRNewswire/ Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and.
/PRNewswire/ Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") and.
Stealth BioTherapeutics Announces Poster Presentation at American College of Cardiology (ACC) Annual Meeting
News provided by
Share this article
Share this article
BOSTON, May 17, 2021 /PRNewswire/ Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced that the company is presenting a poster at the 2021 American College of Cardiology (ACC) meeting being held virtually from May 15-17, 2021.
The poster entitled Elamipretide Improves Functional Assessments when Compared to the Natural History Progression of Cardiomyopathy-related Disease Symptomatology in Patients with Barth Syndrome: A TAZPOWER Analysis presents data from a Phase 3 retrospective natural history control trial comparing the cardiac and functional effects of elamipretide on Barth syndrome patients at week 72 of the open label extension por